Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

NAMs for Clinical Translation of Therapeutics for Systemic Gynecology Diseases

Award Number: UM1TR006029
ORGANIZATION: NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/06/2026
PERIOD OF PERFORMANCE END DATE: 12/31/2030

Group Awards By:

View Award Description

NAMs for Clinical Translation of Therapeutics for Systemic Gynecology Diseases - Specific Aims: NAMs Technology Development Center for Women’s Health, “NAMs TDC-WH” The “NAMs TDC-WH” brings together an international multidisciplinary team, from basic scientists to clinical practitioners, lower the barriers for developing new drugs to treat a spectrum of gynecology disorders ranging from endometriosis to heavy menstrual bleeding and polycystic ovary syndrome (PCOS). This overarching goal will be facilitated by an existing well-funded core infrastructure at MIT in Center for Gynepathology Research that links clinicians, engineers, and scientists in academia and industry to build living patient avatars for endometriosis, adenomyosis and other gynecology diseases (Figure 1. The living patient avatars that will be rigorously tested and translated in the NAMS TDC-WH have been developed since their inception as “combinatorial NAMs”. Computational systems biology and bioinformatics analysis of clinical data (deep phenotyping and -omics) guided the design and operation of microphysiological systems (MPS) to capture key biological phenomena involved in disease and response to drugs, with performance of the MPS benchmarked against in vivo data. For this proposed project, we expand the computational and the clinical teams to capture a more comprehensive picture of the patient population, including genetic diversity and evolving aspects of the pain phenotype. We focus primarily here on combinatorial NAMs for female reproductive tissues, but include liver and other organ systems, recognizing the systemic nature of these diseases and the requirement that any drugs developed with gynecology tissues as a target require metabolic and safety assessments in a systemic manner. We test the hypothesis that pain phenotypes in humans relevant for endometriosis can be captured adequately via the combinatorial NAMs approach. The aims of the TDC-WH are to (i) elevate these technologies to the rigorous criteria needed for regulatory activities related to planning and interpreting human clinical trials for these drugs (ii) further strengthen the ties to the clinical phenotyping, genetics and bioinformatics communities whose input are needed to design physiologically relevant NAMs and benchmark them against in vivo for specific therapeutic targets (iii) translate the NAMs into use via example pre-clinical use cases in collaboration with Pharma. Finally, in addition to the technologies that have already been commercialized or in the process of being commercialized, we aim to translate the new platform technologies under development into wide availability through commercial partners. This will be accomplished through a comprehensive spectrum of education and outreach activities, including videos, hands-on tutorials, and translation of alpha versions of technologies for early feedback on user experience.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $3,262,377 )
2026	2026	MASSACHUSETTS INSTITUTE OF TECHNOLOGY	77 MASSACHUSETTS AVE	CAMBRIDGE	MA	02139	MIDDLESEX	USA	Trans-NIH Research Support	000	1	2/6/2026	NEW	$3,262,377
														Subtotal = $3,262,377

Grand Total All Awards = $3,262,377

Top

All Categories

About

Search

Reports

Data Submission

Award Information

NAMs for Clinical Translation of Therapeutics for Systemic Gynecology Diseases

Award Number: UM1TR006029

ORGANIZATION: NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/06/2026

PERIOD OF PERFORMANCE END DATE: 12/31/2030

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer